2026 Autoimmune Neurology Conference | C20 - CAR-T Cell Therapies and Neurology

Date Saturday 08/08/26

Time 02:45 PM - 04:30 PM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Stacey Clardy, MD, PhD, F�鶹��ýӳ��, Anastasia Zekeridou, MD, PhD, F�鶹��ýӳ��, Eoin P. Flanagan, MBBCh, F�鶹��ýӳ��

Moderator(s) Rachna Malani, MD, Monica E. Loghin, MD

Topic(s) Autoimmune Neurology

Learning Objectives Upon completion of this course, participants should be able to explain the fundamental principles and therapeutic uses of CAR-T cell therapies as they relate to neuroimmunology; identify common neurologic complications associated with CAR-T cell treatment; and implement appropriate diagnostic and management strategies for patients experiencing CAR-T cell-related neurotoxicity.

CME Available 1.75 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Advanced

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Event Timeline
02:45 PM - 03:12 PM CDT	Speaker	CAR-T Cell Therapies: Basic Principles for the Neurologist Dimitrios Mougiakakos
03:12 PM - 03:39 PM CDT	Speaker	Neurological Complications of CAR-T Cell Therapies Bianca Santomasso, MD
03:39 PM - 04:06 PM CDT	Speaker	Neurological Indications for CAR-T Cell Therapies: Now and Into the Future Scott S. Zamvil, MD, PhD, F�鶹��ýӳ��
04:06 PM - 04:16 PM CDT	Speaker	Abstract Presentation #1
04:16 PM - 04:26 PM CDT	Speaker	Abstract Presentation #2

Faculty Disclosures
Rachna Malani, MD	Dr. Malani has nothing to disclose.
Monica E. Loghin, MD	Dr. Loghin has nothing to disclose.
Bianca Santomasso, MD	Dr. Santomasso has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen/Johnson & Johnson. Dr. Santomasso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb. Dr. Santomasso has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kite/Gilead. Dr. Santomasso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for In8bio. Dr. Santomasso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for In8bio. Dr. Santomasso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Pharmaceuticals.
Scott S. Zamvil, MD, PhD, F�鶹��ýӳ��	Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��. The institution of Dr. Zamvil has received research support from Sumaira Foundation. Dr. Zamvil has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion.
Stacey Clardy, MD, PhD, F�鶹��ýӳ��	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/�鶹��ýӳ�� Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. The institution of Dr. Clardy has received research support from Kyverna. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a �鶹��ýӳ�� Summer Meeting CoDirector Travel and Lodging with �鶹��ýӳ��. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Advent Health Florida, Beaumont Health, CCF, Emory, Penn State Health, Mayo Clinic, Walter Reed.
Anastasia Zekeridou, MD, PhD, F�鶹��ýӳ��	The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care.
Eoin P. Flanagan, MBBCh, F�鶹��ýӳ��	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to �鶹��ýӳ�� interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to �鶹��ýӳ�� interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to �鶹��ýӳ�� interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to �鶹��ýӳ�� interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to �鶹��ýӳ�� interests or activities.
Dimitrios Mougiakakos	Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna Therapeutics. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Interius Bio. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AvenCell. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beigene. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kite/Gilead. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dimitrios Mougiakakos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Ari Green, MD	Dr. Green has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from NIH. The institution of Dr. Green has received research support from NIH / NINDS. The institution of Dr. Green has received research support from NIH / NINDS. Dr. Green has received intellectual property interests from a discovery or technology relating to health care.
Priya Dhawan, MD	Dr. Dhawan has nothing to disclose.
Sasha Gupta, MD	Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Legend . Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Ahmed Abdelhak, MD	The institution of Dr. Abdelhak has received research support from German Multiple Sclerosis Society.
Leonie Muller-Jensen, MD	Dr. Muller-Jensen has received personal compensation in the range of $0-$499 for serving as a Compensation for invited lecture with �鶹��ýӳ��.
Michelle A. Hughes, BS	Ms. Hughes has nothing to disclose.
Camille Fouassier	Mrs. Fouassier has nothing to disclose.
Jodi Lipof, MD	Dr. Lipof has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kite/arcellx. Dr. Lipof has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca.
Taylor Hill	Miss Hill has nothing to disclose.
Omar Hernandez	Mr. Hernandez has nothing to disclose.
Bonell Patino-Escobar, MD	Dr. Patino-Escobar has nothing to disclose.
Arun Wiita, MD, PhD	Dr. Wiita has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Wiita has or had stock in Seen Therapeutics.
shagun arora, MD	Dr. arora has nothing to disclose.
Peter H. Sayre, MD, PhD	Dr. Sayre has nothing to disclose.
Serena S. Kwek, PhD	Dr. Kwek has nothing to disclose.
David Oh, MD, PhD	Dr. Oh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revelation Partners. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tatum Biosciences. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartography Biosciences. The institution of Dr. Oh has received research support from Merck Sharp Dohme. The institution of Dr. Oh has received research support from PACT Pharma. The institution of Dr. Oh has received research support from Poseida Therapeutics. The institution of Dr. Oh has received research support from TCR2 Therapeutics. The institution of Dr. Oh has received research support from Roche/Genentech. The institution of Dr. Oh has received research support from Nutcracker Therapeutics. The institution of Dr. Oh has received research support from Amgen. The institution of Dr. Oh has received research support from Allogene. The institution of Dr. Oh has received research support from Clasp Therapeutics. The institution of Dr. Oh has received research support from Janux Therapeutics. Dr. Oh has received intellectual property interests from a discovery or technology relating to health care.
Jun Yan He	Mr. He has nothing to disclose.
Jeffrey L. Wolf, MD	Dr. Wolf has nothing to disclose.
Ajai Chari, MD	Dr. Chari has received personal compensation for serving as an employee of UCSF. Dr. Chari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for abbvie. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for adaptive. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Antegene. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Forus. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Forus. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Chari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Karyopharm. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Chari has received research support from Janssen.
Thomas Martin, MD	Dr. Martin has received personal compensation for serving as an employee of GSK. Dr. Martin has received personal compensation for serving as an employee of Lilly. Dr. Martin has received personal compensation for serving as an employee of Pfizer. Dr. Martin has received personal compensation for serving as an employee of AstraZeneca. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pfizer. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for astrazeneca. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for gsk. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for pfizer. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly and Company. Dr. Martin has received research support from sanofi. Dr. Martin has received research support from janssen. Dr. Martin has received research support from BMS.
Alfred Chung, MD	Dr. Chung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson Innovative Medicine. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers-Squibb. The institution of Dr. Chung has received research support from Abbvie. The institution of Dr. Chung has received research support from Bristol Myers Squibb. The institution of Dr. Chung has received research support from Caelum Biosciences. The institution of Dr. Chung has received research support from CARsgen Therapeutics. The institution of Dr. Chung has received research support from Johnson and Johnson Innovative Medicine . The institution of Dr. Chung has received research support from K36 Therapeutics .
Darren Pan, MD	Dr. Pan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Pan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Pan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron.
Anupama D. Kumar, MD	Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Legend. The institution of Dr. Kumar has received research support from Astrazeneca. The institution of Dr. Kumar has received research support from Bristol Myers Squibb. The institution of Dr. Kumar has received research support from Celgene.
Sarah F. Wesley, MD, MPH	Dr. Wesley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wesley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wesley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics.
Donald Langan, Jr., MD	Dr. Langan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
David Sabatino, PharmD	Dr. Sabatino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Incyte.